688236.SH
春立医疗
SSE · Healthcare · Medical - Devices · CN
CNY 14.24
−1.73%Year over year
Reported trailing growth
- Revenue
- +26.9%
- EBITDA
- —
- EBIT
- +125.1%
- EPS
- +114.9%
- Free cash flow
- —
- Operating cash flow
- +796.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -1.5%
- EBIT
- -2.8%
- Net income
- -4.0%
- EPS
- -3.9%
- Free cash flow
- +177.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026